Radiomics based on HRCT can predict RP-ILD and mortality in anti-MDA5 + dermatomyositis patients: a...
Radiomics based on HRCT can predict RP-ILD and mortality in anti-MDA5 + dermatomyositis patients: a multi-center retrospective study
About this item
Full title
Author / Creator
He, Wenzhang , Cui, Beibei , Chu, Zhigang , Chen, Xiaoyi , Liu, Jing , Pang, Xueting , Huang, Xuan , Yin, Hongkun , Lin, Hui and Peng, Liqing
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
To assess the effectiveness of HRCT-based radiomics in predicting rapidly progressive interstitial lung disease (RP-ILD) and mortality in anti-MDA5 positive dermatomyositis-related interstitial lung disease (anti-MDA5 + DM-ILD).
From August 2014 to March 2022, 160 patients from Institution 1 were retrospectively and consecutively enrolled and we...
Alternative Titles
Full title
Radiomics based on HRCT can predict RP-ILD and mortality in anti-MDA5 + dermatomyositis patients: a multi-center retrospective study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_9d117507bda74b439863e147ee76757b
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9d117507bda74b439863e147ee76757b
Other Identifiers
ISSN
1465-993X,1465-9921
E-ISSN
1465-993X
DOI
10.1186/s12931-024-02843-w
